1. Financial Services

  2. •

    Shell Companies
Apeiron Capital Investment Corp

Apeiron Capital Investment Corp

APN-WT
Apeiron Capital Investment CorpUS flagNew York Stock Exchange
0.05
USD
- -
- -
Apeiron Capital Investment Corp
APN-WT
(New York Stock Exchange)

Recent

price

0.05

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Similar Companies
Hunt Companies Acquisition Corp. I (HTAQ)
Alpha Star Acquisition Corporation (ALSAR)
Blue Whale Acquisition Corp I (BWC)
Signal Hill Acquisition Corp. (SGHL)
Fortistar Sustainable Solutions Corp. (FSSIU)
Keyarch Acquisition Corporation (KYCHU)
Business
Apeiron Capital Investment Corp (APN-WT) operates as a blank check company, or special purpose acquisition company (SPAC), with no significant ongoing operations beyond pursuing a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more target businesses. The company targets opportunities primarily in financial technology, media, gaming and financial services, wealth-advisory, and asset management industries. Incorporated in 2020 and headquartered at 175 Federal Street, Suite 875, Boston, Massachusetts, it trades warrants under the ticker APN-WT on the NYSE. In August 2023, Apeiron terminated its business combination agreement with GIO World Health Ltd and proceeded to liquidation and dissolution, redeeming public shares and ceasing operations as a SPAC, with no reported mergers, acquisitions, funding rounds, or other major changes since that date.